Harvard Bioscience Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Jun 24 | BuyUS$29,100 | James Green | Individual | 10,000 | US$2.91 | |
06 Jun 24 | BuyUS$61,400 | James Green | Individual | 20,000 | US$3.07 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 3,193,231 | 7.32% |
Hedge Funds | 5,103,868 | 11.7% |
General Public | 9,040,729 | 20.7% |
Institutions | 26,273,055 | 60.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,843,650 | US$6.1m | 0% | no data | |||
2,772,700 | US$6.0m | 0.01% | 0.32% | |||
2,715,000 | US$5.9m | 6.16% | 0.65% | |||
2,388,868 | US$5.2m | 8.59% | 6.23% | |||
2,154,052 | US$4.7m | 1.71% | no data | |||
1,908,749 | US$4.1m | 0% | no data | |||
1,865,429 | US$4.0m | -3.11% | 0.15% | |||
1,715,879 | US$3.7m | -6.12% | no data | |||
1,451,450 | US$3.1m | 0.69% | 0.03% | |||
1,335,820 | US$2.9m | 0% | 0.09% | |||
1,200,000 | US$2.6m | 0% | 0.13% | |||
912,599 | US$2.0m | 2.24% | no data | |||
873,614 | US$1.9m | -9.29% | no data | |||
835,213 | US$1.8m | 0% | 0.79% | |||
724,078 | US$1.6m | -2.84% | no data | |||
717,387 | US$1.5m | 1.09% | no data | |||
592,712 | US$1.3m | -61.4% | 1.23% | |||
499,633 | US$1.1m | 0% | no data | |||
491,092 | US$1.1m | 20.6% | 0.32% | |||
478,783 | US$1.0m | 0% | 0.02% | |||
452,036 | US$976.4k | 0.76% | no data | |||
312,399 | US$674.8k | 5.19% | 0.23% | |||
301,225 | US$650.6k | -28.8% | no data | |||
265,254 | US$572.9k | 0% | no data | |||
249,439 | US$538.8k | 0% | no data |